<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0300-9041</journal-id>
<journal-title><![CDATA[Ginecología y obstetricia de México]]></journal-title>
<abbrev-journal-title><![CDATA[Ginecol. obstet. Méx.]]></abbrev-journal-title>
<issn>0300-9041</issn>
<publisher>
<publisher-name><![CDATA[Federación Mexicana de Colegios de Obstetricia y Ginecología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0300-90412023000400006</article-id>
<article-id pub-id-type="doi">10.24245/gom.v91i4.7831</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Tumor trofoblástico de sitio placentario secundario a mola parcial. Reporte de un caso]]></article-title>
<article-title xml:lang="en"><![CDATA[Placental site trophoblastic tumor secondary to partial mole. Report of a case]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Tienda-Pimentel]]></surname>
<given-names><![CDATA[Marcos]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Tienda Gonzáles]]></surname>
<given-names><![CDATA[Marcos]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Santos-Zapata]]></surname>
<given-names><![CDATA[Rosa]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sánchez-Valdivieso]]></surname>
<given-names><![CDATA[Enrique]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,aff1  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Central Miliar, Ginecología y obstetricia  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital Regional de Alta Especialidad de Veracruz Departamento de Cirugía Oncológica ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2023</year>
</pub-date>
<volume>91</volume>
<numero>4</numero>
<fpage>264</fpage>
<lpage>268</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0300-90412023000400006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0300-90412023000400006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0300-90412023000400006&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  ANTECEDENTES:  La enfermedad trofoblástica gestacional es un padecimiento que incluye un grupo de tumores placentarios, consecuencia de una proliferación anormal del tejido del trofoblasto. Se caracteriza por una excesiva elevación de la gonadotrofina coriónica humana que se considera diagnóstica y un predictor pronóstico.  CASO CLÍNICO:  Paciente de 23 años con hiperémesis gravídica y aumento del tamaño del útero mayor para las siete semanas de gestación y cuantificación de las concentraciones de HGC anormalmente elevadas en comparación con su valor basal. Se descartaron los diagnósticos diferenciales de mola parcial hidatiforme, mola completa y embarazo múltiple. Se concluyó que se trataba de enfermedad trofoblástica gestacional. Se procedió a la evacuación de la cavidad uterina de la que se extrajeron abundantes porciones de tejido ovoconformacional y molariforme. El informe de Patología fue: útero arcuato con tumor de sitio placentario, endometritis crónica, cervicitis con metaplasia escamosa, quiste de Nabot y endometrio proliferativo tardío.  CONCLUSIÓN:  Puesto que las pacientes con enfermedad trofoblástica gestacional suelen tener un pronóstico sombrío se sugiere la histerectomía simple para llegar a la curación. Por la agresividad del tumor y resistencia a otros tratamientos es indispensable el monitoreo riguroso semanal de la cuantificación de la HCG.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  BACKGROUND:  Gestational trophoblastic disease is a condition that includes a group of placental tumors resulting from abnormal proliferation of trophoblast tissue. It is characterized by an excessive elevation of human chorionic gonadotropin which is considered diagnostic and a prognostic predictor.  CLINICAL CASE:  23-year-old patient with hyperemesis gravidarum and uterine enlargement greater than 7 weeks&#8217; gestation and abnormally elevated HGC levels compared to baseline. The differential diagnoses of hydatidiform partial mole, complete mole and multiple pregnancy were ruled out. It was concluded that it was gestational trophoblastic disease. The uterine cavity was evacuated and abundant portions of ovoconformal and molariform tissue were extracted. The pathology report was: arcuate uterus with placental site tumor, chronic endometritis, cervicitis with squamous metaplasia, Nabot&#8217;s cyst and late proliferative endometrium.  CONCLUSION:  Since patients with gestational trophoblastic disease usually have a dismal prognosis simple hysterectomy is suggested to reach cure. Because of the aggressiveness of the tumor and resistance to other treatments, rigorous weekly monitoring of HCG quantification is indispensable.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Enfermedad trofoblástica gestacional]]></kwd>
<kwd lng="es"><![CDATA[placenta]]></kwd>
<kwd lng="es"><![CDATA[gonadotropina coriónica humana]]></kwd>
<kwd lng="es"><![CDATA[hiperémesis gravídica]]></kwd>
<kwd lng="es"><![CDATA[agrandamiento uterino]]></kwd>
<kwd lng="es"><![CDATA[gestación]]></kwd>
<kwd lng="es"><![CDATA[embarazo]]></kwd>
<kwd lng="en"><![CDATA[Gestational trophoblastic disease]]></kwd>
<kwd lng="en"><![CDATA[Placental]]></kwd>
<kwd lng="en"><![CDATA[Human Chorionic gonadotropin]]></kwd>
<kwd lng="en"><![CDATA[Hyperemesis gravidarum]]></kwd>
<kwd lng="en"><![CDATA[Uterine enlargement]]></kwd>
<kwd lng="en"><![CDATA[Gestation]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Strickland]]></surname>
<given-names><![CDATA[A.L]]></given-names>
</name>
<name>
<surname><![CDATA[Gwin]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Gestational trophoblastic disease-rare, sometimes dramatic, and what we know so far]]></article-title>
<source><![CDATA[Semin Diagn Pathol]]></source>
<year>2022</year>
<volume>39</volume>
<page-range>228-37</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gadduci]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Carinelli]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Guerrieri]]></surname>
<given-names><![CDATA[M.E]]></given-names>
</name>
<name>
<surname><![CDATA[Aletti]]></surname>
<given-names><![CDATA[G.D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Placental site trophoblastic tumor and epithelioid trophoblastic tumor: Clinical and pathological features, prognostic variables and treatment strategy]]></article-title>
<source><![CDATA[J Gynecol Oncol]]></source>
<year>2019</year>
<volume>153</volume>
<page-range>684-93</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jauniaux]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Memtsa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Johns]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rossb]]></surname>
<given-names><![CDATA[J.A]]></given-names>
</name>
<name>
<surname><![CDATA[Sebirec]]></surname>
<given-names><![CDATA[N.J]]></given-names>
</name>
<name>
<surname><![CDATA[Jurkovica]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ultrasound diagnosis of complete and partial hydatidiform moles in early pregnancy failure: An inter-observer study]]></article-title>
<source><![CDATA[Placenta]]></source>
<year>2020</year>
<volume>97</volume>
<page-range>65-7</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dudiak]]></surname>
<given-names><![CDATA[K.M]]></given-names>
</name>
<name>
<surname><![CDATA[Maturen]]></surname>
<given-names><![CDATA[K.E]]></given-names>
</name>
<name>
<surname><![CDATA[Akin]]></surname>
<given-names><![CDATA[E.A]]></given-names>
</name>
<name>
<surname><![CDATA[Bell]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[ACR Appropriateness Criteria Gestational Trophoblastic Disease]]></article-title>
<source><![CDATA[JACR]]></source>
<year>2019</year>
<volume>16</volume>
<page-range>S348-63</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eiriksson]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Dean]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Sebastianelli]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Salvador]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guideline No. 408: Management of Gestational Trophoblastic Diseases]]></article-title>
<source><![CDATA[JOGC]]></source>
<year>2021</year>
<volume>43</volume>
<page-range>91-105</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Horowitz]]></surname>
<given-names><![CDATA[N.S]]></given-names>
</name>
<name>
<surname><![CDATA[Goldstein]]></surname>
<given-names><![CDATA[D.P]]></given-names>
</name>
<name>
<surname><![CDATA[Berkowitz]]></surname>
<given-names><![CDATA[R.S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Placental site trophoblastic tumors and epithelioid trophoblastic tumors: Biology, natural history, and treatment modalities]]></article-title>
<source><![CDATA[Gynecol Oncol]]></source>
<year>2017</year>
<volume>144</volume>
<page-range>208-14</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hernández Flores]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Vega Memije]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Niebla Cardenas]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidencia de Enfermedad Trofoblastica Gestacional en un Hospital General]]></article-title>
<collab>Audifred Salomon JR et al</collab>
<source><![CDATA[Ginecol Obstet Mex]]></source>
<year>2016</year>
<volume>84</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>377-82</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nadhana]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Vamanb]]></surname>
<given-names><![CDATA[J.V]]></given-names>
</name>
<name>
<surname><![CDATA[Sengodana]]></surname>
<given-names><![CDATA[S. K]]></given-names>
</name>
<name>
<surname><![CDATA[Hemalatha]]></surname>
<given-names><![CDATA[K. S]]></given-names>
</name>
<name>
<surname><![CDATA[Rajan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Insights into dovetailing GTD and Cancers]]></article-title>
<source><![CDATA[Criti Rev Oncol Hematol]]></source>
<year>2017</year>
<volume>144</volume>
<page-range>77-90</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Braga]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Paiva]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Ghorani]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Freitas]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study]]></article-title>
<source><![CDATA[Lancet Oncol]]></source>
<year>2021</year>
<volume>22</volume>
<page-range>1188-98</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
